Osaic Holdings’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69 Sell
10
-13
-57% -$121 ﹤0.01% 7658
2025
Q4
$209 Hold
23
﹤0.01% 7574
2025
Q3
$512 Hold
23
﹤0.01% 7547
2025
Q2
$463 Hold
23
﹤0.01% 7364
2025
Q1
$618 Buy
23
+10
+77% +$371 ﹤0.01% 6949
2024
Q4
$414 Hold
13
﹤0.01% 7059
2024
Q3
$288 Hold
13
﹤0.01% 7113
2024
Q2
$471 Hold
13
﹤0.01% 6999
2024
Q1
$718 Buy
13
+11
+550% +$776 ﹤0.01% 6750
2023
Q4
$164 Hold
2
﹤0.01% 7065
2023
Q3
$143 Hold
2
﹤0.01% 7191
2023
Q2
$273 Hold
2
﹤0.01% 7156
2023
Q1
$202 Sell
2
-67
-97% -$6.39K ﹤0.01% 7266
2022
Q4
$6K Sell
69
-1,540
-96% -$141K ﹤0.01% 6185
2022
Q3
$107K Buy
1,609
+317
+25% +$27.3K ﹤0.01% 4305
2022
Q2
$96K Buy
1,292
+19
+1% +$2.22K ﹤0.01% 4454
2022
Q1
$2.41M Buy
1,273
+386
+44% +$81.8K ﹤0.01% 1781
2021
Q4
$301K Sell
887
-154
-15% -$59.6K ﹤0.01% 3562
2021
Q3
$455K Buy
1,041
+360
+53% +$126K ﹤0.01% 3122
2021
Q2
$237K Buy
681
+134
+24% +$51.9K ﹤0.01% 3724
2021
Q1
$200K Buy
547
+543
+13,575% +$223K ﹤0.01% 3733
2020
Q4
$2K Hold
4
﹤0.01% 6047
2020
Q3
$2K Hold
4
﹤0.01% 5833
2020
Q2
$3K Hold
4
﹤0.01% 5646
2020
Q1
$2K Buy
+4
New +$1.94K ﹤0.01% 5657

Other funds holding CUE

Osaic Holdings's CUE Position: Q1 2026 in Review

Osaic Holdings reduced its Cue Biopharma (CUE) stake by 57% in Q1 2026, selling an estimated $121 and leaving 10 shares worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #7658.

Osaic Holdings first reported a position in CUE in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.41M in Q1 2022. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Osaic Holdings held 10 shares of Cue Biopharma worth $69 as of Q1 2026.
  • Osaic Holdings sold 13 Cue Biopharma shares in Q1 2026, an estimated $121.
  • Cue Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7658 holding.
  • Osaic Holdings first reported a position in Cue Biopharma in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Cue Biopharma position peaked at $2.41M in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.